Boxer Capital LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 1:13 pm Sale |
2022-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 698,861 2.000% |
-1,540,000 (-68.78%) |
Filing |
| 2022-02-14 4:54 pm Sale |
2021-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 2,238,861 7.500% |
-238,333 (-9.62%) |
Filing |
| 2021-02-16 4:57 pm Purchase |
2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 2,477,194 8.300% |
700,000 (+39.39%) |
Filing |
| 2020-08-03 4:31 pm Purchase |
2020-07-23 | 13G | Milestone Pharmaceuticals Inc. MIST |
Boxer Capital LLC | 1,777,194 7.200% |
1,777,194 (New Position) |
Filing |